Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luke R Smart

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
BMC Medicine|November 16, 2020
AnemoCheck-LRS: an optimized, color-based point-of-care test to identify severe anemia in limited-resource settingsMarina S Perez-Plazola, Erika A Tyburski, Luke R Smart, et al.
Plos Neglected Tropical Diseases|August 18, 2017
Increased hepatotoxicity among HIV-infected adults co-infected with Schistosoma mansoni in Tanzania: A cross-sectional studyAmon I Marti, Soledad Colombe, Peter J Masikini, et al.
Annals of Hematology|November 18, 2017
Simultaneous point-of-care detection of anemia and sickle cell disease in Tanzania: the RAPID studyLuke R Smart, Emmanuela E Ambrose, Kevin C Raphael, et al.
The Lancet. Haematology|March 4, 2023
Hydroxyurea with dose escalation for primary stroke risk reduction in children with sickle cell anaemia in Tanzania (SPHERE): an open-label, phase 2 trialEmmanuela E Ambrose, Teresa S Latham, Primrose Songoro, et al.
Heart (British Cardiac Society)|April 24, 2016
Short-term and long-term cardiovascular risk, metabolic syndrome and HIV in TanzaniaJustin R Kingery, Yona Alfred, Luke R Smart, et al.
The Lancet. Haematology|May 3, 2024
Hydroxyurea dose optimisation for children with sickle cell anaemia in sub-Saharan Africa (REACH): extended follow-up of a multicentre, open-label, phase 1/2 trialBanu Aygun, Adam Lane, Luke R Smart, et al.
Plos One|June 21, 2019
Very severe anemia and one year mortality outcome after hospitalization in Tanzanian children: A prospective cohort studyNeema Chami, Duncan K Hau, Tulla S Masoza, et al.
Trials|September 22, 2023
Prospective identification of variables as outcomes for treatment (PIVOT): study protocol for a randomised, placebo-controlled trial of hydroxyurea for Ghanaian children and adults with haemoglobin SC diseaseLuke R Smart, Catherine I Segbefia, Teresa S Latham, et al.
BMC Infectious Diseases|June 5, 2014
Oesophageal varices, schistosomiasis, and mortality among patients admitted with haematemesis in Mwanza, Tanzania: a prospective cohort studyAwilly A Chofle, Hyasinta Jaka, Mheta Koy, et al.
Bulletin of the World Health Organization|December 9, 2020
Surveillance for sickle cell disease, United Republic of TanzaniaEmmanuela E Ambrose, Luke R Smart, Mwesige Charles, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
BMC Medicine|November 16, 2020
AnemoCheck-LRS: an optimized, color-based point-of-care test to identify severe anemia in limited-resource settingsMarina S Perez-Plazola, Erika A Tyburski, Luke R Smart, et al.
Plos Neglected Tropical Diseases|August 18, 2017
Increased hepatotoxicity among HIV-infected adults co-infected with Schistosoma mansoni in Tanzania: A cross-sectional studyAmon I Marti, Soledad Colombe, Peter J Masikini, et al.
Annals of Hematology|November 18, 2017
Simultaneous point-of-care detection of anemia and sickle cell disease in Tanzania: the RAPID studyLuke R Smart, Emmanuela E Ambrose, Kevin C Raphael, et al.
The Lancet. Haematology|March 4, 2023
Hydroxyurea with dose escalation for primary stroke risk reduction in children with sickle cell anaemia in Tanzania (SPHERE): an open-label, phase 2 trialEmmanuela E Ambrose, Teresa S Latham, Primrose Songoro, et al.
Heart (British Cardiac Society)|April 24, 2016
Short-term and long-term cardiovascular risk, metabolic syndrome and HIV in TanzaniaJustin R Kingery, Yona Alfred, Luke R Smart, et al.
The Lancet. Haematology|May 3, 2024
Hydroxyurea dose optimisation for children with sickle cell anaemia in sub-Saharan Africa (REACH): extended follow-up of a multicentre, open-label, phase 1/2 trialBanu Aygun, Adam Lane, Luke R Smart, et al.
Plos One|June 21, 2019
Very severe anemia and one year mortality outcome after hospitalization in Tanzanian children: A prospective cohort studyNeema Chami, Duncan K Hau, Tulla S Masoza, et al.
Trials|September 22, 2023
Prospective identification of variables as outcomes for treatment (PIVOT): study protocol for a randomised, placebo-controlled trial of hydroxyurea for Ghanaian children and adults with haemoglobin SC diseaseLuke R Smart, Catherine I Segbefia, Teresa S Latham, et al.
BMC Infectious Diseases|June 5, 2014
Oesophageal varices, schistosomiasis, and mortality among patients admitted with haematemesis in Mwanza, Tanzania: a prospective cohort studyAwilly A Chofle, Hyasinta Jaka, Mheta Koy, et al.
Bulletin of the World Health Organization|December 9, 2020
Surveillance for sickle cell disease, United Republic of TanzaniaEmmanuela E Ambrose, Luke R Smart, Mwesige Charles, et al.
Pageof 5